Bruno Geloneze

Navedeno

	Vse	Od leta 2020
Navedbe	49656	29384
indeks h	56	36
indeks i10	126	85

7000

3500

1750

5250

200820092010201120122013201420152016201720182019202020212022202320242025177 268 293 395 557 697 748 890 2264 3494 4288 4624 5878 6280 5749 5264 5158 1019

Javni dostop

Prikaži vse

17 člankov

1 članek

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

Jose Carlos ParejaUniversidade Estadual de CampinasPreverjeni e-poštni naslov na obesidadesevera.com.br
Ana Carolina Junqueira VasquesUniversidade Estadual de CampinasPreverjeni e-poštni naslov na fca.unicamp.br
Elinton ChaimUniversidade Estadual de CampinasPreverjeni e-poštni naslov na hc.unicamp.br
LICIO Augusto VellosoProfessor of Medicine, University of CampinasPreverjeni e-poštni naslov na unicamp.br
Mario José Abdalla SaadProfessor Titular da Faculdade de Ciências Médicas - FCM, UNICAMPPreverjeni e-poštni naslov na fcm.unicamp.br
Everton CazzoProfessor Associado Livre Docente; Universidade Estadual de CampinasPreverjeni e-poštni naslov na unicamp.br
Gil Guerra-JuniorUNICAMPPreverjeni e-poštni naslov na fcm.unicamp.br
Eliete BouskelaProfessora Titular de Fisiologia Cardiovascular, Universidade do Estado do Rio de JaneiroPreverjeni e-poštni naslov na pq.cnpq.br
Dennys Esper CintraUniversity of CampinasPreverjeni e-poštni naslov na unicamp.br
Foued Salmen EspindolaUniversidade Federal de UberlândiaPreverjeni e-poštni naslov na ufu.br
MARCIO CORRÊA ManciniHead of the Obesity and Metabolic Syndrome Unit at the Department of Endocrinology and MetabolismPreverjeni e-poštni naslov na hc.fm.usp.br
Adriana Aparecida Siviero-MiachonProfessora Adjunta, Departamento de Pediatria, Universidade Federal de São Paulo - UNIFESP/EPMPreverjeni e-poštni naslov na unifesp.br
Angela Maria Spinola e CastroUniversidade Federal de São PauloPreverjeni e-poštni naslov na angelaspinola.com.br
Fernando CendesFull Professor, Department of Neurology, FCM, University of Campinas - UNICAMP, BrazilPreverjeni e-poštni naslov na unicamp.br
Celia Regina GarlippUniversidade Estadual de CampinasPreverjeni e-poštni naslov na hc.unicamp.br
Rita de Cássia Gonçalves AlfenasProfessor de Nutrição, Universidade Federal de ViçosaPreverjeni e-poštni naslov na ufv.br
Dioze GuadagniniUNICAMPPreverjeni e-poštni naslov na fcm.unicamp.br
Andrea TuraPreverjeni e-poštni naslov na isib.cnr.it
Marciane MilanskiProfessora do Curso de Nutrição, Faculdade de Ciências Aplicadas - UnicampPreverjeni e-poštni naslov na fca.unicamp.br
luciana mela UmedaUniversidade Federal de São PauloPreverjeni e-poštni naslov na unifesp.br

Spremljaj

Bruno Geloneze

Professor of Endocrinology and Diabetes, Obesity and Comorbities Research Center UNICAMP Brazil

Preverjeni e-poštni naslov na unicamp.br

Endocrinology Diabetes Obesity Bariatric Surgery GLP-1


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes ISE Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus ... New England Journal of Medicine 373 (22), 2117-28, 2015	13623	2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes M SP, D GH, Brown-Frandsen K, K P, M JF, N MA, N SE, P S, P NR, R LS, ... New England Journal of Medicine 375 (4), 311-322, 2016	7917	2016
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy MKW Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM ... New England Journal of Medicine 380 (24), 2295-2306, 2019	5884	2019
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. MM Wanner C1, Inzucchi SE1, Lachin JM1, Fitchett D1, von Eynatten M1, ... New England Journal of Medicine 375 (4), 323-334, 2016	4199	2016
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. WJP Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau ... New England Journal of Medicine 373 (1), 11-22, 2015	2567	2015
Liraglutide and Renal Outcomes in Type 2 Diabetes BJB Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S ... New England Journal of Medicine 377 (9), 839-848, 2017	1330	2017
Pratical recommendations for the management of diabetes in patients with COVID-19 SR Bernstein, F Rubino, K Khunti, G Mingrone, D Hopkins, AL Birkenfeld, ... The Lancet Diabetes & Endocrinology, 00, 2020	1120	2020
IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia AC Sposito, B Caramelli, FAH Fonseca, MC Bertolami, A Afiune Neto, ... Arquivos brasileiros de cardiologia 88, 2-19, 2007	979*	2007
Long-term weight regain after gastric bypass: a 5-year prospective study DO Magro, B Geloneze, R Delfini, BC Pareja, F Callejas, JC Pareja Obesity surgery 18 (6), 648-651, 2008	880	2008
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. PSX le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz ... Lancet 140 (17), 30069-7, 2017	849*	2017
The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 … MLMP Jorge, VN de Oliveira, NM Resende, LF Paraiso, A Calixto, ... Metabolism 60 (9), 1244-1252, 2011	667	2011
I Diretriz sobre o consumo de gorduras e saúde cardiovascular RD Santos, ACM Gagliardi, HT Xavier, CD Magnoni, R Cassani, ... Arquivos Brasileiros de Cardiologia 100, 1-40, 2013	624	2013
TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study ACJ Vasques, FS Novaes, MS de Oliveira, JRM Souza, A Yamanaka, ... Diabetes research and clinical practice 93 (3), e98-e100, 2011	598	2011
HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS) B Geloneze, ACJ Vasques, CFC Stabe, JC Pareja, LEFP Rosado, ... Arquivos Brasileiros de Endocrinologia & Metabologia 53 (2), 281-287, 2009	429	2009
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26 … BMK Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M ... Diabetes Care 35 (2), 252-8, 2012	413	2012
The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. B Geloneze, EM Repetto, SR Geloneze, MA Tambascia, MN Ermetice Diabetes Research and Clinical Practice 72 (2), 219, 2006	354	2006
Neck Circumference as a Simple Tool for Identifying the Metabolic Syndrome and Insulin Resistance: Results from the Brazilian Metabolic Syndrome Study (BRAMS) C Stabe, ACJ Vasques, MMO Lima, MA Tambascia, JC Pareja, ... Clinical Endocrinology, 2012	335	2012
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics PV Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S ... American Journalof Nephrology 46 (6), 462-472, 2017	265*	2017
Ghrelin: a gut-brain hormone: effect of gastric bypass surgery B Geloneze, MA Tambascia, VF Pilla, SR Geloneze, EM Repetto, ... Obesity surgery 13 (1), 17-22, 2003	254	2003
COVID-19 and metabolic disease: mechanisms and clinical management C Steenblock, PEH Schwarz, B Ludwig, A Linkermann, P Zimmet, ... The lancet Diabetes & endocrinology 9 (11), 786-798, 2021	249	2021

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji